Groundbreaking AI Technology Receives FDA Approval
RapidAI has achieved a significant milestone with FDA 510(k) clearance for their revolutionary Lumina 3D system. This automated 3D imaging reconstruction solution leverages cutting-edge AI technology to replace traditional…
What You Should Know:
– The global AI medical imaging market is experiencing a period of rapid expansion, fueled by technological advancements, increasing government initiatives, and a growing demand for more efficient and accurate diagnostic…
Continue Reading
Strategic Acquisition Enhances AI Capabilities
ScreenPoint Medical’s acquisition of Biomediq A/S on January 8, 2025, represents a milestone in AI-driven breast cancer detection. This strategic merger follows ten years of collaborative research, integrating Biomediq’s quantitative…
What You Should Know:
– GE HealthCare and Mass General Brigham, longstanding partners in artificial intelligence (AI) research, have announced a new initiative focused on integrating medical imaging foundation models into their work. This collaboration…
Continue Reading
Microsoft has continued to accelerate its drive into AI tools for health, with the launch of a series of new analytics and AI services, as part of its new Fabric data analytics platform and…
Continue Reading
AstraZeneca has tied up with Institut Kanser Negara, a centre of excellence for cancer care in Malaysia, to incorporate AI medical imaging into early lung cancer screening at government clinics and hospitals. WHY IT MATTERS
Lung…
Artificial intelligence can be safely used to improve the accuracy of screening of mammography results, according to a new study published in The Lancet Oncology.More than 80,000 women between the ages of 40 and 80,…
Continue Reading
